All News #Library
Others
Leyden Labs Confirms Potential of Intranasal Antibody Approach
08 Apr 2025 //
BUSINESSWIRE
Leyden Labs Licenses Pan-Influenza Antibody from Janssen
18 Jan 2022 //
GLOBENEWSWIRE

Market Place
Sourcing Support